Skip to Main Content

Author Details

Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
1992
242
55
PMIDPaper TitleJournal TitlePublished Year
36306337Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.Blood Adv2023
38024241Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.Neurooncol Adv2023
37539043Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma.iScience2023
37566280Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma.Ann Hematol2023
37182582Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer.Mod Pathol2023
37038467Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.Hemasphere2023
36971477Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell.Cancer Res2023
37200058DNA or RNA? Classification of B-cell lymphomas.Blood2023
37197629False positivity in break apart fluorescence in-situ hybridization due to polyploidy.Transl Lung Cancer Res2023
37327081Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.Inflamm Bowel Dis2023
36564280Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer.Clin Colorectal Cancer2023
36069231Oral cancer prediction by noninvasive genetic screening.Int J Cancer2023
34743329Tumor-immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas.J Pathol2022
35489024Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.Int J Cancer2022
35816682Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.Blood Adv2022
35782751A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).Ther Adv Med Oncol2022
35813096Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment.Hemasphere2022
35933522A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma.Leukemia2022
36237330Chromosome 11q loss and <i>MYCN</i> amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.Front Oncol2022
35863110Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts.Eur J Cancer2022
35927254Molecular characterization of colorectal cancer related peritoneal metastatic disease.Nat Commun2022
36055228Detection and localization of early- and late-stage cancers using platelet RNA.Cancer Cell2022
36387143The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.Front Oncol2022
35129727Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.Gastric Cancer2022
34912077Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study.Br J Cancer2022
35267654Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma.Cancers (Basel)2022
34230973Engineering large-scale chromosomal deletions by CRISPR-Cas9.Nucleic Acids Res2021
33504550Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).Clin Cancer Res2021
34671028Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data.Nat Commun2021
34454114PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach.J Mol Diagn2021
34045449Chromosomal copy number heterogeneity predicts survival rates across cancers.Nat Commun2021
33964451Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.J Mol Diagn2021
34099699Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing.Nat Commun2021
34295456Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma.J Extracell Vesicles2021
31340061Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.Int J Cancer2020
34367618The ELIXIR Human Copy Number Variations Community: building bioinformatics infrastructure for research.F1000Res2020
31695154Two types of primary mucinous ovarian tumors can be distinguished based on their origin.Mod Pathol2020
33331925Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.Blood2020
33103128Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.Cell Rep Med2020
32585557Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.Oral Oncol2020
32555399Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.Sci Rep2020
32460198Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment.Lung Cancer2020
32512811Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study.J Clin Med2020
31372648IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.Inflamm Bowel Dis2020
30510084Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.Blood2019
31743370Correction: Clonality analysis of pulmonary tumors by genome-wide copy number profiling.PLoS One2019
32328554Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review.JNCI Cancer Spectr2019
30224542Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.Mol Cancer Res2019
31277718Genomic imbalances defining novel intellectual disability associated loci.Orphanet J Rare Dis2019
31618260Clonality analysis of pulmonary tumors by genome-wide copy number profiling.PLoS One2019
  • 1 - 50 of 242

Recommended Authors

Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 14
Darawalee Wangsa
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Career Start Year 2004
Number of shared co-authors 2
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 15
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 13
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 21
Jordi Camps
Universitat Autonoma de Barcelona
Career Start Year 2003
Number of shared co-authors 6
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 9
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Peter J Park
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 14
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 22
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 1
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 14
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 15
Danny Wangsa
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 1
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 9
Jane Bayani
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 8
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 4
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 31
Thomas Ried
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 8
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 23
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 15
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 12

Collaborators

Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 79
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Co-authored papers 46
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 21
Oscar Krijgsman
The Netherlands Cancer Institute
Co-authored papers 18
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 15
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 11
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers 8
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Co-authored papers 6
Diether Lambrechts
Co-authored papers 6
Thomas Wurdinger
Co-authored papers 6
Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers 6
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 6
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 6
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 6
Rut Klinger
UCD Conway Institute, University College Dublin
Co-authored papers 5
Remond J A Fijneman
The Netherlands Cancer Institute
Co-authored papers 5
Eric J T Belt
Albert Schweitzer Hospital
Co-authored papers 4
Manon van Engeland
Maastricht University Medical Center
Co-authored papers 4
Joe W Gray
Oregon Health and Science University
Co-authored papers 4
Wim Van Criekinge
Ghent University
Co-authored papers 4
Louis Vermeulen
Oncode Institute
Co-authored papers 4
Josephine C Dorsman
Cancer Center Amsterdam
Co-authored papers 4
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers 4
Jan Paul Medema
Oncode Institute
Co-authored papers 3
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers 3
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 3
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 3
Andries M Bergman
The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital
Co-authored papers 3
Christian Benner
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 3
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 2
Release 1.2